AAAAAA
Results:
1-18
|
Results: 18
Authors:
OGATA K
AN E
KAMIKUBO K
YOKOSE N
TAMURA H
YAMADA T
GOMI S
DAN K
NOMURA T
Citation: K. Ogata et al., REPEALED CYCLES OF G-CSF-COMBINED POSTREMISSION CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA IN A FIRST COMPLETE REMISSION - A PILOT-STUDY, Stem cells, 16(4), 1998, pp. 280-287
Authors:
YOKOSE N
OGATA K
TAMURA H
AN E
NAKAMURA K
KAMIKUBO K
KUDOH S
DAN K
NOMURA T
Citation: N. Yokose et al., PULMONARY TOXICITY AFTER GRANULOCYTE-COLONY-STIMULATING FACTOR-COMBINED CHEMOTHERAPY FOR NON-HODGKINS-LYMPHOMA, British Journal of Cancer, 77(12), 1998, pp. 2286-2290
Authors:
YOKOSE N
OGATA K
Citation: N. Yokose et K. Ogata, PLASMA SOLUBLE INTERLEUKIN-2 RECEPTORS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Leukemia & lymphoma, 28(1-2), 1997, pp. 171-176
Authors:
YOKOSE N
OGATA K
NAKAMURA K
KAMIKUBO K
TAMURA H
AN E
DAN K
NOMURA T
Citation: N. Yokose et al., HYPOFIBRINOGENEMIA INDUCED BY PREDNISOLONE THERAPY IN A PATIENT WITH CHRONIC LYMPHOCYTIC-LEUKEMIA COMPLICATED WITH AUTOIMMUNE HEMOLYTIC-ANEMIA, American journal of hematology, 55(3), 1997, pp. 166-167
Authors:
OGATA K
AN E
KAMIKUBO K
TAMURA H
YOKOSE N
DAN KZ
NOMURA T
Citation: K. Ogata et al., CELL-CYCLE MODULATION BY HEMATOPOIETIC GROWTH-FACTORS IN MYELODYSPLASTIC SYNDROMES - ANALYSIS BY 3-COLOR FLOW-CYTOMETRY, Experimental hematology, 25(1), 1997, pp. 8-18
Authors:
OGATA K
YOKOSE N
TAMURA H
AN E
NAKAMURA K
DAN K
NOMURA T
Citation: K. Ogata et al., NATURAL-KILLER-CELLS IN THE LATE DECADES OF HUMAN LIFE, Clinical immunology and immunopathology, 84(3), 1997, pp. 269-275
Authors:
TAMURA H
OGATA K
YOKOSE N
AN E
KAMIKUBO K
DAN K
KAJII E
NOMURA T
Citation: H. Tamura et al., AUTOIMMUNE HEMOLYTIC-ANEMIA IN PATIENTS WITH DE-NOVO ACUTE MYELOCYTIC-LEUKEMIA, Annals of hematology, 72(1), 1996, pp. 45-47
Authors:
OGATA K
TAMURA H
YOKOSE N
DAN K
NOMURA T
Citation: K. Ogata et al., CD4 LYMPHOPENIA AND RISK OF INFECTION IN IMMUNOGERONTOLOGICALLY HEALTHY ELDERLY PEOPLE, Lancet, 347(9012), 1996, pp. 1408-1408
Authors:
OGATA K
YOKOSE N
AN E
KAMIKUBO K
TAMURA H
DAN K
SAKAMAKI H
ONOZAWA Y
HAMAGUCHI H
NOMURA T
Citation: K. Ogata et al., PLASMA SOLUBLE INTERLEUKIN-2 RECEPTOR LEVEL IN PATIENTS WITH PRIMARY MYELODYSPLASTIC SYNDROMES - A RELATIONSHIP WITH DISEASE SUBTYPE AND CLINICAL OUTCOME, British Journal of Haematology, 93(1), 1996, pp. 45-52
Authors:
OGATA K
YOKOSE N
NOMURA T
Citation: K. Ogata et al., INTERLEUKIN-2 THERAPY FOR MYELODYSPLASTIC SYNDROME - DOES IT WORK, Leukemia & lymphoma, 17(5-6), 1995, pp. 411-415
Authors:
YOKOSE N
OGATA K
AN E
TAMURA H
KAMIKUBO K
DAN K
NOMURA T
Citation: N. Yokose et al., LINEAGE-UNRESTRICTED HEMATOLOGIC RESPONSE TO GRANULOCYTE-COLONY-STIMULATING FACTOR IN A PATIENT WITH REFRACTORY-ANEMIA WITH EXCESS BLASTS, Annals of hematology, 70(3), 1995, pp. 163-167
Authors:
YOKOSE N
TANABE Y
AN E
OSAMURA Y
Citation: N. Yokose et al., ACUTE GASTRIC-MUCOSAL LESIONS ASSOCIATED WITH CYTOMEGALOVIRUS-INFECTION IN A NONIMMUNOCOMPROMISED HOST, Internal medicine, 34(9), 1995, pp. 883-885
Authors:
OGATA K
TAMURA H
YOKOSE N
AN E
DAN K
HAMAGUCHI H
SAKAMAKI H
ONOZAWA Y
CLARK SC
NOMURA T
Citation: K. Ogata et al., EFFECTS OF INTERLEUKIN-12 ON NATURAL-KILLER-CELL CYTOTOXICITY AND THEPRODUCTION OF INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES, British Journal of Haematology, 90(1), 1995, pp. 15-21
Authors:
YOKOSE N
OGATA K
DAN K
NOMURA T
Citation: N. Yokose et al., APLASTIC-ANEMIA WITH CIRCULATING ERYTHROBLASTS, International journal of hematology, 60(2), 1994, pp. 111-117
Authors:
YOKOSE N
OGATA K
ITO T
AN EM
TAMURA H
DAN KZ
HAMAGUCHI H
SAKAMAKI H
ONOZAWA Y
NOMURA T
Citation: N. Yokose et al., ELEVATED PLASMA SOLUBLE INTERLEUKIN-2 RECEPTOR LEVEL CORRELATES WITH DEFECTIVE NATURAL-KILLER AND CD8-CELLS IN MYELODYSPLASTIC SYNDROMES( T), Leukemia research, 18(10), 1994, pp. 777-782
Authors:
OGATA K
FUJII H
YOKOSE N
AN E
TAMURA H
KAMIKUBO K
DAN K
HAMAGUCHI H
SAKAMAKI H
ONOZAWA Y
NOMURA T
Citation: K. Ogata et al., DEFECTIVE NATURAL-KILLER (NK) CELL-MEDIATED CYTOTOXICITY DOES NOT IMPLY CLONAL INVOLVEMENT OF NK CELLS IN MYELODYSPLASTIC SYNDROMES, British Journal of Haematology, 87(2), 1994, pp. 396-398
Authors:
OGATA K
YOKOSE N
ITO T
AN E
TAMURA H
DAN K
HAMAGUCHI H
SAKAMAKI H
Citation: K. Ogata et al., ASSESSMENT OF THERAPEUTIC POTENTIAL OF INTERLEUKIN-2 FOR MYELODYSPLASTIC SYNDROMES, British Journal of Haematology, 86(3), 1994, pp. 562-567
Authors:
KURIYA S
OGATA K
AN E
HAMAGUCHI H
YOKOSE N
ANZAI Y
NOMURA T
Citation: S. Kuriya et al., A NOVEL MEGAKARYOCYTE POTENTIATOR PRODUCED BY MC-1 HUMAN LUNG-CANCER CELL-LINE, Pathobiology, 61(5-6), 1993, pp. 256-267
Risultati:
1-18
|